Cargando…
COVID‐19 in a patient with severe asthma treated with Omalizumab
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323189/ https://www.ncbi.nlm.nih.gov/pubmed/32544254 http://dx.doi.org/10.1111/all.14456 |
| _version_ | 1783551754100539392 |
|---|---|
| author | Lommatzsch, Marek Stoll, Paul Virchow, Johann Christian |
| author_facet | Lommatzsch, Marek Stoll, Paul Virchow, Johann Christian |
| author_sort | Lommatzsch, Marek |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7323189 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73231892020-06-29 COVID‐19 in a patient with severe asthma treated with Omalizumab Lommatzsch, Marek Stoll, Paul Virchow, Johann Christian Allergy Letters to the Editor John Wiley and Sons Inc. 2020-06-27 2020-10 /pmc/articles/PMC7323189/ /pubmed/32544254 http://dx.doi.org/10.1111/all.14456 Text en © 2020 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Lommatzsch, Marek Stoll, Paul Virchow, Johann Christian COVID‐19 in a patient with severe asthma treated with Omalizumab |
| title | COVID‐19 in a patient with severe asthma treated with Omalizumab |
| title_full | COVID‐19 in a patient with severe asthma treated with Omalizumab |
| title_fullStr | COVID‐19 in a patient with severe asthma treated with Omalizumab |
| title_full_unstemmed | COVID‐19 in a patient with severe asthma treated with Omalizumab |
| title_short | COVID‐19 in a patient with severe asthma treated with Omalizumab |
| title_sort | covid‐19 in a patient with severe asthma treated with omalizumab |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323189/ https://www.ncbi.nlm.nih.gov/pubmed/32544254 http://dx.doi.org/10.1111/all.14456 |
| work_keys_str_mv | AT lommatzschmarek covid19inapatientwithsevereasthmatreatedwithomalizumab AT stollpaul covid19inapatientwithsevereasthmatreatedwithomalizumab AT virchowjohannchristian covid19inapatientwithsevereasthmatreatedwithomalizumab |